MO/PP: TB Treatment

Target Audience

• Private Provider

• MO/PP: Anti-TB Drug Formulations and regimens

  • Strategies for TB Treatment
  • Treatment Phases
  • TB Drug Regimen
  • First line anti TB drugs
  • Second Line anti TB drugs
  • Fixed Dose Combinations [FDC]s
  • Advantages of FDCs
  • FDCs used in NTEP

• MO/PP: DS-TB Treatment and Care

  • Drug-Sensitive Tuberculosis [DS-TB]
  • Treatment Regimen for DSTB – Adult
  • Treatment Regimen for DSTB - Pediatrics
  • TB Treatment Initiation
  • Start Treatment for DSTB patient & DRTB patient
  • Follow-up of TB patient
  • Follow-up sputum examination
  • TB Treatment Outcome
  • Closing Cases and Assigning Treatment Outcomes
  • Long Term Post-treatment follow up of TB patients
  • Reinitiating case

• MO/PP: Treatment Support

  • Treatment Support Mechanism
  • Treatment Support Plan
  • Treatment supporter [TS] to TB Patient

• MO/PP: Adherence Management

  • TB Treatment Adherence
  • Importance of Treatment adherence
  • Directly Observed Treatment [DOT]
  • Digital Adherence Monitoring Technologies
  • Recording and Monitoring Adherence
  • Recording manual doses in Ni-kshay
  • Recording missed doses in Ni-kshay
  • Recording Adherence using TB Arogya Sathi Application

• MO/PP: TB and Comorbidity

  • HIV testing of individuals with presumed or confirmed TB
  • Linkage to TB-HIV services in the private sector
  • Co-trimoxazole prophylactic therapy in persons with HIV and TB coinfection
  • Isoniazid Preventive Therapy [IPT] in People Living with HIV [PLHIV]
  • TB and Diabetes comorbidity
  • Diabetes among people with TB
  • Malnutrition among people with TB
  • Alcoholism among people with TB
  • Tobacco use among people with TB
  • Silicosis in people with TB
  • Cancer in People with TB
  • TB in Pregnant and Lactating Women

• MO/PP: ADRs to ATT

  • Adverse Drug Reactions [ADRs]
  • Types of ADR of TB Treatment
  • Management of Adverse Drug Reactions [ADRs] of TB Treatment

• MO/PP: Overview of DR-TB treatment and care

  • DR-TB Centres and Network
  • Cascade of Care for DR-TB Patients in the Private Sector
  • DR-TB Treatment Regimens
  • ADRs to Second Line Treatment
  • Manage TB India Application
  • Pre-treatment Counselling
  • Pre treatment evaluation of DRTB cases
  • Interim Treatment Outcomes of DR-TB Cases
  • Final Treatment Outcomes of DR-TB Cases
  • Follow-up Monitoring of DR-TB Patients
  • Follow up sputum examination for DR-TB

• MO/PP: Management of Isoniazid (H) Mono/Poly DR-TB

  • Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen
  • Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
  • Adverse Drug Events: H Mono/Poly DR-TB Regimen
  • Replacement Sequence in the H Mono/Poly DR-TB

• How NTEP can support Private Practitioners/Hospitals in TB Treatment Services

  H5Content